Other languages ANGN BIOM

Equities

ANGN

US03476J1079

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
9.22 ^USD	-5.34%		-4.26%	-7.80%

2023	Angion Biomedica Corp. Announces Resignation of Assaf Segal from Its Board of Directors	CI
2023	Angion Biomedia to Implement 10-for-1 Reverse Split	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Angion Biomedica Corp. Announces Resignation of Assaf Segal from Its Board of Directors	23-08-30
Angion Biomedia to Implement 10-for-1 Reverse Split	23-06-01
Elicio Therapeutics, Inc. completed the acquisition of Angion Biomedica Corp. from Vifor (International) AG, Eisa-Abc LLC and others in a reverse merger transaction.	23-05-31
Angion Biomedica Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Sector Update: Health Care Stocks Finishing Near Intra-Day Lows	23-01-17
Sector Update: Health Care Stocks Sputtering in Tuesday Trading	23-01-17
Top Midday Decliners	23-01-17
Investors Digest More Big Bank Earnings, Weighing on US Equity Futures	23-01-17
Top Premarket Decliners	23-01-17
Angion Biomedica Agrees to Merge With Elicio Therapeutics	23-01-17
Angion Biomedica Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Angion Biomedica Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
Earnings Flash (ANGN) ANGION BIOMEDICA Posts Q2 Revenue $653,000	22-08-15
Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder Value	22-07-25
Angion Biomedica Corp. Announces Resignation of John F. Neylan as Chief Medical Officer and Head of Research, Effective on August 15, 2022	22-07-25
Sector Update: Health Care Stocks Little Changed on Thursday	22-06-30
Sector Update: Health Care	22-06-30
Angion Biomedica Corp. Announces Discontinuation of Phase 2 Trial of ANG-3070 in Patients with Primary Proteinuric Kidney Disease	22-06-29
Angion Biomedica Files $100 Million Mixed Shelf	22-05-17
Angion Biomedica Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ANGN BIOM

Equities

ANGN

US03476J1079

Other languages

Filters